asparagine Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 4126 | 70-47-3 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
A non-essential amino acid that is involved in the metabolic control of cell functions in nerve and brain tissue. It is biosynthesized from ASPARTIC ACID and AMMONIA by asparagine synthetase. (From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed)
|
Drug dosage:
None
ADMET properties:
None
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| CHEBI has role | CHEBI:27027 | trace elements |
| CHEBI has role | CHEBI:50733 | nutritional supplement |
| CHEBI has role | CHEBI:75771 | mus musculus metabolite |
| CHEBI has role | CHEBI:75772 | baker's yeast metabolite |
| CHEBI has role | CHEBI:76924 | plant metabolites |
| CHEBI has role | CHEBI:76971 | e.coli metabolites |
| CHEBI has role | CHEBI:77746 | h. sapiens metabolites |
| CHEBI has role | CHEBI:83056 | daphnia magna metabolites |
| CHEBI has role | CHEBI:84735 | algal metabolites |
Drug Use (View source of the data)
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 2.1 | acidic |
| pKa2 | 12.1 | acidic |
| pKa3 | 8.83 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| 5Z33R5TKO7 | UNII |
| N0000170238 | NUI |
| D09738 | KEGG_DRUG |
| C0003995 | UMLSCUI |
| CHEBI:22653 | CHEBI |
| ASN | PDB_CHEM_ID |
| CHEMBL58832 | ChEMBL_ID |
| DB00174 | DRUGBANK_ID |
| D001216 | MESH_DESCRIPTOR_UI |
| 6267 | PUBCHEM_CID |
| 4533 | IUPHAR_LIGAND_ID |
| 1157 | RXNORM |
| 006909 | NDDF |
| 34744002 | SNOMEDCT_US |
| 87136001 | SNOMEDCT_US |
Pharmaceutical products:
None